Bank of New York Mellon’s UROPLASTY INC-NEW UPI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-11,557
Closed -$14K 4413
2015
Q1
$14K Sell
11,557
-400
-3% -$539 ﹤0.01% 4207
2014
Q4
$25K Buy
11,957
+400
+3% +$950 ﹤0.01% 4203
2014
Q3
$29K Hold
11,557
﹤0.01% 4183
2014
Q2
$31K Hold
11,557
﹤0.01% 4112
2014
Q1
$42K Hold
11,557
﹤0.01% 4097
2013
Q4
$32K Sell
11,557
-95
-0.8% -$290 ﹤0.01% 4149
2013
Q3
$38K Buy
11,652
+95
+0.8% +$265 ﹤0.01% 4075
2013
Q2
$24K Buy
+11,557
New +$26.5K ﹤0.01% 4104

Bank of New York Mellon's UPI Position: Q2 2015 in Review

Bank of New York Mellon sold out of UROPLASTY INC-NEW (UPI) in Q2 2015, closing a stake of 11,557 shares — an estimated $14K sold.

Bank of New York Mellon first reported a position in UPI in Q2 2013 and held it in 8 quarters. The position peaked at $42K in Q1 2014. 0 funds tracked by Wall St. Rank hold UPI as of Q2 2015.

  • Bank of New York Mellon reported no remaining UROPLASTY INC-NEW position as of Q2 2015 after selling out during the quarter.
  • Bank of New York Mellon sold 11,557 UROPLASTY INC-NEW shares in Q2 2015, an estimated $14K.
  • Bank of New York Mellon first reported a position in UROPLASTY INC-NEW in Q2 2013 and held it in 8 quarters.
  • Bank of New York Mellon's UROPLASTY INC-NEW position peaked at $42K in Q1 2014.
  • 0 funds tracked by Wall St. Rank held UROPLASTY INC-NEW as of Q2 2015.

Based on Bank of New York Mellon's 13F filing for Q2 2015, filed 6 Aug 2015.